The “Global Viscosupplementation Market, Size, Global Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis” report has been added to ResearchAndMarkets.com’s offering.
Global Viscosupplementation Market is expected to reach US$ 6.27 Billion by 2028 according to the publisher. Patients with osteoarthritis have a minimally invasive therapeutic option called viscosupplementation.
During viscosupplementation, hyaluronic acid is pushed into the joints. The synovial fluid that covers joints contains hyaluronic acid, a substance that occurs naturally. It lubricates joints to allow bones to move freely and lessen discomfort. Hyaluronic acid levels in the joints are lower in those with osteoarthritis, which causes pain.
According to the research findings, Worldwide Viscosupplementation market was US$ 3.71 Billion in 2022.
Global Viscosupplementation Market will grow with 9.14% CAGR during the forecast period:
The increase in the incidence of osteoarthritis, the rise in the geriatric population, and the hike in the number of product launches and product approvals are the main factors driving the growth of the global viscosupplementation market size. One of the most prevalent types of arthritis is osteoarthritis.
In 2019, the Centers for Disease Control and Prevention estimated that 32.5 million Americans (1 in 7 adults) had osteoarthritis. Due to an increase in chronic diseases like obesity, diabetes, and heart disease, the prevalence of osteoarthritis has reached alarming levels. Additionally, a lack of physical activity, such as exercise, increases the requirement for osteoarthritis treatment for the knee and hip and propels market expansion.
Single Injection Viscosupplementation holds the lion’s share
By procedure, the Viscosupplementation market is divided into three segments, i.e., Single Injection Viscosupplementation, Three Injection Viscosupplementation, and Five Injections Viscosupplementation. Among all, Single Injection dominates the current viscosupplementation market. The demand for outpatient surgeries that offer same-day surgical care, including preventive (surgical) and diagnostic procedures, is driving the Single Injections Segment. Furthermore, an increase in product launches and focus on developing single injections for the treatment of osteoarthritis are expected to contribute to the significant growth of the single-injection market over the forecast period.
By Application: The Knee Osteoarthritis Segment dominates the Market Share
Due to the increased prevalence of knee osteoarthritis and the growing geriatric population, who are more vulnerable to knee osteoarthritis, the knee osteoarthritis segment dominated the Viscosupplementation market and is anticipated to maintain this trend over the projected period. In addition, the ageing effect, which reduces the amount of water in cartilage and further reduces its capacity to absorb shock and cushion, makes the elderly population more susceptible to developing knee osteoarthritis.
Orthopedic clinics/Ambulatory Surgical Centers Segment is growing at a Significant Growth Rate
By End users, the Viscosupplementation market is segmented into Hospitals and Orthopedic clinics/Ambulatory Surgical Centers. Outpatient service sites, particularly those that provide ambulatory surgery and physician office-based treatments, have grown into fierce competitors for hospitals due to the recent adoption of value-based care. Orthopedic clinics/Ambulatory Surgical Centers offer both practical and financial benefits, such as quicker patient access, more affordable prices, more opportunities for physician involvement, and outpatient facilities. Hence they acquire a dominant market share in the Viscosupplementation market.
By Region: North America and Asia Pacific holds a Significant Market Share
North America occupies a dominant position in the global viscosupplementation market. The factors contributing to the growth of viscosupplementation in the North American region are the increased prevalence of osteoarthritis and related ailments, the ageing population, the well-established healthcare system, and the rising desire for non-surgical procedures. Furthermore, Asia Pacific is expected to grow with a notable growth rate during the forecast period due to the increase in the geriatric population and rising healthcare expenditures.
1. Single Injection Viscosupplementation
2. Three Injections Viscosupplementation
3. Five Injections Viscosupplementation
1. Knee Osteoarthritis
2. Hip Osteoarthritis
3. Hand/Wrist Osteoarthritis
4. Ankle/Foot Osteoarthritis
2. Orthopedic clinics/Ambulatory Surgical Centers
1. North America
3. Asia Pacific
4. Rest of World
1. Anika Therapeutics Inc.
3. Zimmer Biomet
4. Smith & Nephew PLC
5. Lifecore Biomedical
6. LG Life Sciences Ltd.
7. F.Hoffmann-La Roche Ltd.
8. Chugai Pharmaceutical Co.
Key Topics Covered:
2. Research & Methodology
3. Executive Summary
4. Market Dynamics
5. Global Viscosupplementation Market
6. Market Share – Global Viscosupplementation Analysis
7. Product – Global Viscosupplementation Market
8. Application – Global Viscosupplementation Market
9. End User – Global Viscosupplementation Market
10. Region – Global Viscosupplementation Market
11. Company Analysis
For more information about this report visit https://www.researchandmarkets.com/r/nx5odw
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets